3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Endometrial Neoplasms
3
Stomach Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Thrombophilia
1
Thrombocytopenia
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Cancer Extensive Stage
1
Salivary Gland Neoplasms
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Myelosuppression
1
Myeloproliferative Disorders
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukopenia
1
Leiomyoma
1
Hypersplenism
1
Hemoglobinuria, Paroxysmal
1
Hematologic Diseases
1
Growth Hormone-Secreting Pituitary Adenoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Liver Metastases
1
Interventions
Specimen Handling
2
Endoscopy
2
tremelimumab
1
futibatinib
1
durvalumab
1
Taxes
1
Risk Assessment
1
Ramucirumab
1
Radiofrequency Ablation
1
Paclitaxel
1
Oxaliplatin
1
Observation
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Itraconazole
1
Folfox protocol
1
Fluorouracil
1
Breath Tests
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Adenocarcinoma Of Esophagus
×
Observation
×
Clear all
NCT06933966
2025-04-18
ATTENUATION
Centre Leon Berard
Phase 2
Not yet recruiting
120 enrolled